Evidence map›Paper›PMID 35873349›Full record

ArticleFrontiers in digital health2022

Evaluating the COVID-19 Identification ResNet (CIdeR) on the INTERSPEECH COVID-19 From Audio Challenges.

Alican Akman, Harry Coppock, Alexander Gaskell, Panagiotis Tzirakis, Lyn Jones, Björn W Schuller

Abstract read
In one paragraph

Article in Frontiers in digital health, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Deep learning on multi-view sequential data: a survey.Artificial intelligence review · 2023
    Article
  3. A summary of the ComParE COVID-19 challenges.Frontiers in digital health · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Alican AkmanGLAM-Group on Language, Audio, and Music, Imperial College London, London, United Kingdom.
Harry CoppockGLAM-Group on Language, Audio, and Music, Imperial College London, London, United Kingdom.
Alexander GaskellGLAM-Group on Language, Audio, and Music, Imperial College London, London, United Kingdom.
Panagiotis TzirakisGLAM-Group on Language, Audio, and Music, Imperial College London, London, United Kingdom.
Lyn JonesDepartment of Radiology, North Bristol NHS Trust, Bristol, United Kingdom.
Björn W SchullerGLAM-Group on Language, Audio, and Music, Imperial College London, London, United Kingdom.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Several machine learning-based COVID-19 classifiers exploiting vocal biomarkers of COVID-19 has been proposed recently as digital mass testing methods. Although these classifiers have shown strong performances on the datasets on which they are trained, their methodological adaptation to new datasets with different modalities has not been explored. We report on cross-running the modified version of recent COVID-19 Identification ResNet (CIdeR) on the two Interspeech 2021 COVID-19 diagnosis from cough and speech audio challenges: ComParE and DiCOVA. CIdeR is an end-to-end deep learning neural network originally designed to classify whether an individual is COVID-19-positive or COVID-19-negative based on coughing and breathing audio recordings from a published crowdsourced dataset. In the current study, we demonstrate the potential of CIdeR at binary COVID-19 diagnosis from both the COVID-19 Cough and Speech Sub-Challenges of INTERSPEECH 2021, ComParE and DiCOVA. CIdeR achieves significant improvements over several baselines. We also present the results of the cross dataset experiments with CIdeR that show the limitations of using the current COVID-19 datasets jointly to build a collective COVID-19 classifier.

Indexed as

audiocomputer auditionCOVID-19deep learningdigital health

Identifiers

PMID35873349
PMCPMC9302571

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.